Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

yorkshire_moors_dales_yorkshire_landscape_england_countryside_english_rural-497670

Those living in rural areas less likely to survive cancer, study shows

December 13, 2018 Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban

Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
News

Government choose England top pharmacist to address overprescribing and polypharmacy

December 13, 2018 Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma

England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
News

NICE reject two treatments for fatal, ultra-rare disease – hATTR

December 13, 2018 Medical Communications, Research and Development, Sales and Marketing

The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …
News
pharmafocus_dec_2018_cover

The December issue of Pharmafocus is available to read online now!

December 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
News
daphne_karydas

Allergan strengthens Finance Leadership Team with two appointments

December 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, MIT, Regeneron, appointment, pharma

The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …
Appointment
ben_osborne

Pfizer announces new UK Managing Director

December 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales

New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …
Appointment
maps-2018-01-boulder-staged-lana-marcela-bruce-bryce-img_20180128_135008_preview

Psychedelic therapy: A new approach to mental health

December 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy

In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …
Feature

Gilead names Roche veteran Daniel O’Day as new CEO

December 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Gilead, Roche, appointment

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …
News
28246711066_52e38bc591_z

Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit

December 7, 2018 Medical Communications Matt Hancock, NHS, UK, brexit, no-deal

British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …
News
gilead-sciences

NICE give go-ahead to Gilead’s Yescarta for adults with lymphoma

December 7, 2018 Medical Communications Cancer, Cost, Gilead, NHS, NICE, Yescarta, access

The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will …
News
gehrynovartis

Novartis CEO calls for cultural shift to cater for millennial generation

December 7, 2018 Medical Communications Business, company, culture, millenials. Novartis

The CEO of Swiss multinational Novartis has said that he wants to ‘un-boss’ the multi-billion pound company while relaxing the …
News
AstraZeneca

AstraZeneca’s head and neck cancer treatment Imfinzi falls flat in Phase III trials

December 7, 2018 Medical Communications AstraZeneca, Cancer, oncology, phase III, treatment

AstraZeneca’s immunotherapy treatment Imfinzi has failed to meet its primary goal in treating head and neck cancer in the Phase …
News
jeffrey_hackman

EUSA Pharma take on Novelion CEO Jeffrey Hackman to lead US expansion

December 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Hertfordshire-based speciality pharma firm EUSA Pharma has appointed Jeffrey S Hackman as President of the company’s United States operations. …
Appointment

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

December 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025